Federation Bio

📍 South San Francisco, United States🗓 Founded 2019👥 43 employees💰 Last funded Apr 2020
Biotechnology Research🌐 federation.bio
Website LinkedIn
Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company’s microbial approach leverages naturally occurring bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses. This approach has potential in a diverse set of human conditions ranging from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions. Federation Bio’s lead program is in secondary hyperoxaluria, a serious renal condition that affects more than 200,000 Americans and for which there are currently no approved therapies. Additional information can be found at www.federation.bio
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Hong Kong SAR
1
Frequently asked questions
Who invested in Federation Bio?
Federation Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Federation Bio last raise funding?
The most recent investment in Federation Bio recorded on gritt.io was in April 2020.
When was Federation Bio founded?
Federation Bio was founded in 2019.
What industry is Federation Bio in?
Federation Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Federation Bio based?
Federation Bio is headquartered in South San Francisco, United States.